Related references
Note: Only part of the references are listed.Chronic administration of Tat-GluR23Y ameliorates cognitive dysfunction targeting CREB signaling in rats with amyloid beta neurotoxicity
Fatemeh Ashourpour et al.
METABOLIC BRAIN DISEASE (2021)
Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin
Liang Wang et al.
CELL RESEARCH (2020)
A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats
Yewei Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
MeCP2 links heterochromatin condensates and neurodevelopmental disease
Charles H. Li et al.
NATURE (2020)
MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons
Aya Ito-Ishida et al.
JOURNAL OF NEUROSCIENCE (2020)
An electrochemiluminescence based assay for quantitative detection of endogenous and exogenously applied MeCP2 protein variants
Hannes Steinkellner et al.
SCIENTIFIC REPORTS (2019)
Efficient and Precise CRISPR/Cas9-Mediated MECP2 Modifications in Human-Induced Pluripotent Stem Cells
Thi Thanh Huong Le et al.
FRONTIERS IN GENETICS (2019)
MeCP2: A Critical Regulator of Chromatin in Neurodevelopment and Adult Brain Function
Kubra Gulmez Karaca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
Alexia Martinez de Paz et al.
EPIGENETICS & CHROMATIN (2019)
Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage
Su Bin Cho et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder
Stefania Trazzi et al.
HUMAN MOLECULAR GENETICS (2018)
MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation
Taimoor I. Sheikh et al.
HUMAN MOLECULAR GENETICS (2017)
Radically truncated MeCP2 rescues Rett syndromelike neurological defects
Rebekah Tillotson et al.
NATURE (2017)
Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders
Valdeko Kruusvee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
MeCP2 mutations: progress towards understanding and treating Rett syndrome
Ruth R. Shah et al.
GENOME MEDICINE (2017)
Histone deacetylase 3 associates with MeCP2 to regulate FOXO and social behavior
Alexi Nott et al.
NATURE NEUROSCIENCE (2016)
Rett Syndrome: Crossing the Threshold to Clinical Translation
David M. Katz et al.
TRENDS IN NEUROSCIENCES (2016)
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
Lukasz Swiech et al.
NATURE BIOTECHNOLOGY (2015)
Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons
Yun Li et al.
CELL STEM CELL (2013)
Systemic Delivery of MeCP2 Rescues Behavioral and Cellular Deficits in Female Mouse Models of Rett Syndrome
Saurabh K. Garg et al.
JOURNAL OF NEUROSCIENCE (2013)
Improved Survival and Reduced Phenotypic Severity Following AAV9/MECP2 Gene Transfer to Neonatal and Juvenile Male Mecp2 Knockout Mice
Kamal K. E. Gadalla et al.
MOLECULAR THERAPY (2013)
Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes
Bredford Kerr et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows
Helene Cheval et al.
HUMAN MOLECULAR GENETICS (2012)
Methyl CpG-binding Protein Isoform MeCP2_e2 Is Dispensable for Rett Syndrome Phenotypes but Essential for Embryo Viability and Placenta Development
Masayuki Itoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS
Angela Dann et al.
NATURE NEUROSCIENCE (2012)
Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
Cornelia Brendel et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
SYNAPTIC PLASTICITY DEFICITS IN AN EXPERIMENTAL MODEL OF RETT SYNDROME: LONG-TERM POTENTIATION SATURATION AND ITS PHARMACOLOGICAL REVERSAL
S-M Weng et al.
NEUROSCIENCE (2011)
Aminoglycoside-Mediated Partial Suppression of MECP2 Nonsense Mutations Responsible for Rett Syndrome In Vitro
Andreea C. Popescu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Correction of respiratory disorders in a mouse model of Rett syndrome
Ana P. L. Abdala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Novel Exon 1 Mutations in MECP2 Implicate Isoform MeCP2_e1 in Classical Rett Syndrome
Carol J. Saunders et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform
Yann Fichou et al.
NEUROGENETICS (2009)
Suppression of Nonsense Mutations in Rett Syndrome by Aminoglycoside Antibiotics
Cornelia Brendel et al.
PEDIATRIC RESEARCH (2009)
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Daniela Tropea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Evolving role of MeCP2 in Rett syndrome and autism
Janine M. LaSalle et al.
EPIGENOMICS (2009)
MeCP2, a key contributor to neurological disease, activates and represses transcription
Maria Chahrour et al.
SCIENCE (2008)
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome
Michael Ogier et al.
JOURNAL OF NEUROSCIENCE (2007)
Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis
Matias Alvarez-Saavedra et al.
HUMAN MOLECULAR GENETICS (2007)
Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome
Jean-Christophe Roux et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Reversal of neurological defects in a mouse model of Rett syndrome
Jacky Guy et al.
SCIENCE (2007)
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2
Emanuela Giacometti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo
H. Akiko Popiel et al.
MOLECULAR THERAPY (2007)
TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice
Ana Toro et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Reduced MeCP2 Expression is Frequent in Autism Frontal Cortex and Correlates with Aberrant MECP2 Promoter Methylation
Raman P. Nagarajan et al.
EPIGENETICS (2006)
Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory
Bing Gong et al.
CELL (2006)
An altered neonatal behavioral phenotype in Mecp2 mutant mice
JD Picker et al.
NEUROREPORT (2006)
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males
H Van Esch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Defining the pathway for tat-mediated delivery of β-glucuronidase in cultured cells and MPS VII mice
KO Orii et al.
MOLECULAR THERAPY (2005)
Cell-penetrating peptides: Mechanisms and applications
S El-Andaloussi et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice
S Luikenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome
GN Mnatzakanian et al.
NATURE GENETICS (2004)
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
AL Collins et al.
HUMAN MOLECULAR GENETICS (2004)
Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake
JP Richard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors
HB Xia et al.
NATURE BIOTECHNOLOGY (2001)
Guidelines for reporting clinical features in cases with MECP2 mutations
AM Kerr et al.
BRAIN & DEVELOPMENT (2001)
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome
MM Wan et al.
HUMAN MOLECULAR GENETICS (2001)
MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin
R Trappe et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
J Guy et al.
NATURE GENETICS (2001)
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
RZ Chen et al.
NATURE GENETICS (2001)
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells
NJ Caron et al.
MOLECULAR THERAPY (2001)
Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo
ZB Mi et al.
MOLECULAR THERAPY (2000)
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients:: correlation of disease severity with mutation type and location
JP Cheadle et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
